These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 23459489)

  • 1. Detection of linezolid-resistant Staphylococcus aureus with 23S rRNA and novel L4 riboprotein mutations in a cystic fibrosis patient in Spain.
    Román F; Roldán C; Trincado P; Ballesteros C; Carazo C; Vindel A
    Antimicrob Agents Chemother; 2013 May; 57(5):2428-9. PubMed ID: 23459489
    [No Abstract]   [Full Text] [Related]  

  • 2. Emergence of linezolid-resistant Staphylococcus aureus during treatment of pulmonary infection in a patient with cystic fibrosis.
    Gales AC; Sader HS; Andrade SS; Lutz L; Machado A; Barth AL
    Int J Antimicrob Agents; 2006 Apr; 27(4):300-2. PubMed ID: 16527459
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Linezolid resistance in Staphylococcus aureus: gene dosage effect, stability, fitness costs, and cross-resistances.
    Besier S; Ludwig A; Zander J; Brade V; Wichelhaus TA
    Antimicrob Agents Chemother; 2008 Apr; 52(4):1570-2. PubMed ID: 18212098
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Resistance to linezolid in a methicillin-susceptible Staphylococcus aureus clinical isolate without previous exposure to oxazolidinones.
    Quiles-Melero I; García-Perea A; de Pablos M; Gómez-Gil R; Mingorance J
    Int J Med Microbiol; 2012 Jul; 302(3):145-7. PubMed ID: 22578666
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rapid emergence of resistance to linezolid and mutator phenotypes in Staphylococcus aureus isolates from an adult cystic fibrosis patient.
    Tazi A; Chapron J; Touak G; Longo M; Hubert D; Collobert G; Dusser D; Poyart C; Morand PC
    Antimicrob Agents Chemother; 2013 Oct; 57(10):5186-8. PubMed ID: 23917314
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polyphyletic emergence of linezolid-resistant staphylococci in the United States.
    Wong A; Reddy SP; Smyth DS; Aguero-Rosenfeld ME; Sakoulas G; Robinson DA
    Antimicrob Agents Chemother; 2010 Feb; 54(2):742-8. PubMed ID: 19933808
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanisms of linezolid resistance among Staphylococci in a tertiary hospital.
    Quiles-Melero I; Gómez-Gil R; Romero-Gómez MP; Sánchez-Díaz AM; de Pablos M; García-Rodriguez J; Gutiérrez A; Mingorance J
    J Clin Microbiol; 2013 Mar; 51(3):998-1001. PubMed ID: 23269737
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Linezolid resistance in sequential Staphylococcus aureus isolates associated with a T2500A mutation in the 23S rRNA gene and loss of a single copy of rRNA.
    Meka VG; Pillai SK; Sakoulas G; Wennersten C; Venkataraman L; DeGirolami PC; Eliopoulos GM; Moellering RC; Gold HS
    J Infect Dis; 2004 Jul; 190(2):311-7. PubMed ID: 15216466
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Persistence of rRNA operon mutated copies and rapid re-emergence of linezolid resistance in Staphylococcus aureus.
    Tsakris A; Pillai SK; Gold HS; Thauvin-Eliopoulos C; Venkataraman L; Wennersten C; Moellering RC; Eliopoulos GM
    J Antimicrob Chemother; 2007 Sep; 60(3):649-51. PubMed ID: 17623697
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel ribosomal mutations in Staphylococcus aureus strains identified through selection with the oxazolidinones linezolid and torezolid (TR-700).
    Locke JB; Hilgers M; Shaw KJ
    Antimicrob Agents Chemother; 2009 Dec; 53(12):5265-74. PubMed ID: 19752277
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Two novel point mutations in clinical Staphylococcus aureus reduce linezolid susceptibility and switch on the stringent response to promote persistent infection.
    Gao W; Chua K; Davies JK; Newton HJ; Seemann T; Harrison PF; Holmes NE; Rhee HW; Hong JI; Hartland EL; Stinear TP; Howden BP
    PLoS Pathog; 2010 Jun; 6(6):e1000944. PubMed ID: 20548948
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutations in ribosomal protein L3 are associated with oxazolidinone resistance in staphylococci of clinical origin.
    Locke JB; Hilgers M; Shaw KJ
    Antimicrob Agents Chemother; 2009 Dec; 53(12):5275-8. PubMed ID: 19805557
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tedizolid for the management of human infections: in vitro characteristics.
    Locke JB; Zurenko GE; Shaw KJ; Bartizal K
    Clin Infect Dis; 2014 Jan; 58 Suppl 1():S35-42. PubMed ID: 24343830
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevated linezolid resistance in clinical cfr-positive Staphylococcus aureus isolates is associated with co-occurring mutations in ribosomal protein L3.
    Locke JB; Morales G; Hilgers M; G C K; Rahawi S; José Picazo J; Shaw KJ; Stein JL
    Antimicrob Agents Chemother; 2010 Dec; 54(12):5352-5. PubMed ID: 20837755
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and microbiological aspects of linezolid resistance mediated by the cfr gene encoding a 23S rRNA methyltransferase.
    Arias CA; Vallejo M; Reyes J; Panesso D; Moreno J; Castañeda E; Villegas MV; Murray BE; Quinn JP
    J Clin Microbiol; 2008 Mar; 46(3):892-6. PubMed ID: 18174304
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Linezolid resistance in Staphylococcus aureus: characterization and stability of resistant phenotype.
    Pillai SK; Sakoulas G; Wennersten C; Eliopoulos GM; Moellering RC; Ferraro MJ; Gold HS
    J Infect Dis; 2002 Dec; 186(11):1603-7. PubMed ID: 12447736
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reversion to susceptibility in a linezolid-resistant clinical isolate of Staphylococcus aureus.
    Meka VG; Gold HS; Cooke A; Venkataraman L; Eliopoulos GM; Moellering RC; Jenkins SG
    J Antimicrob Chemother; 2004 Oct; 54(4):818-20. PubMed ID: 15347637
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Linezolid dependence in Staphylococcus epidermidis bloodstream isolates.
    Pournaras S; Ntokou E; Zarkotou O; Ranellou K; Themeli-Digalaki K; Stathopoulos C; Tsakris A
    Emerg Infect Dis; 2013 Jan; 19(1):129-32. PubMed ID: 23260390
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of pyrosequencing to identify point mutations in domain V of 23S rRNA genes of linezolid-resistant Staphylococcus aureus and Staphylococcus epidermidis.
    Zhu W; Tenover FC; Limor J; Lonsway D; Prince D; Dunne WM; Patel JB
    Eur J Clin Microbiol Infect Dis; 2007 Mar; 26(3):161-5. PubMed ID: 17393201
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Linezolid resistance in Brazilian Staphylococcus hominis strains is associated with L3 and 23S rRNA ribosomal mutations.
    de Almeida LM; de Araújo MR; Sacramento AG; Pavez M; de Souza AG; Rodrigues F; Gales AC; Lincopan N; Sampaio JL; Mamizuka EM
    Antimicrob Agents Chemother; 2013 Aug; 57(8):4082-3. PubMed ID: 23689714
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.